Selank vs Semax

Yes. Both are registered medicines with Russian regulatory approval. Selank is marketed for generalized anxiety disorder, semax for post-stroke recovery and related neurological indications. They are prescription and over-the-counter in Russia depending on the indication. This regulatory status does not extend outside Russia and a handful of former Soviet states - neither has FDA approval, neither has EMA approval, neither has any major Western regulatory recognition. Russian approval standards are different from Western standards and do not automatically translate.

Semax, by a clear margin. 2025 has seen active preclinical research on semax effects on BDNF (brain-derived neurotrophic factor), spinal cord injury recovery, and Alzheimer's-model work. Selank has thinner current research activity, with most of its evidence base dating to older Russian clinical studies. Neither has received substantial independent Western validation. The semax research is mostly still in rodent and cell culture models, but the activity level is noticeably higher than anything on the selank side.

Not for human use. Both are sold as research chemicals labeled not for human consumption by a small set of suppliers that specialize in Russian peptides. There is no FDA pathway, no legitimate pharmacy supply, and no prescribing doctor in the US. Both typically ship as intranasal spray formulations, with monthly costs around $40-80. Quality control on suppliers varies widely. For practical purposes, anyone using these is participating in a self-experiment with no clinical oversight.

There is no good data to support that claim. Selank and semax lack the large-scale safety databases that FDA-approved psychiatric and cognitive medications have accumulated over decades. They may have cleaner subjective side effect profiles in the short term - Russian clinical data suggests selank is non-sedating and well-tolerated - but there is no long-term human safety data from independent sources, no large RCTs, and no post-marketing surveillance infrastructure outside Russia. 'Safer' and 'fewer reported side effects' are not the same thing as 'proven safe.'

Selank works via Synthetic peptide analog of tuftsin that modulates GABA, serotonin, and norepinephrine for. Semax works via Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects. They differ in FDA approval status, efficacy data, and cost.

Selank typically costs $40 - $80/mo, while Semax costs $45 - $90/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.

Selank is not FDA-approved (Not submitted). Semax is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.

Common side effects of Selank include Nasal irritation, Mild drowsiness, Headache. Common side effects of Semax include Nasal irritation, Mild stimulation, Headache. Always consult a healthcare provider about potential side effects.

Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.